A retrospective observational study of early experiences of vedolizumab treatment for inflammatory bowel disease in the UK-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A retrospective observational study of early experiences of vedolizumab treatment for inflammatory bowel disease in the UK

Published:2019-03 Issue:9 Volume:98 Page:e14681
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Cummings Fraser,Gaya Daniel R.,Levison Scott,Subramanian Sreedhar,Owen Glynn,Rathmell Anna,Glen Fiona,Demuth Dirk,Meadowcroft Simon,Irving Peter M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference22 articles.

1. Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed;Gisbert;Aliment Pharmacol Ther,2015

2. Selective biologics for ulcerative colitis and Crohn's disease—clinical utility of vedolizumab;Petkau;Biol Targets Ther,2016

3. Loss of response to anti-TNFs: definition, epidemiology, and management;Roda;Clin Transl Gastroenterol,2016

4. Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects;Allez;J Crohns Colitis,2010

5. Inflammatory bowel disease patients are frequently nonadherent to scheduled induction and maintenance infliximab therapy: a Canadian cohort study;Ma;Can J Gastroenterol Hepatol,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review;Journal of Managed Care & Specialty Pharmacy;2024-09

2. Biologics in Focus: A Comprehensive Review of Current Biological and Small Molecules Therapies for Crohn’s Disease in the United Arab Emirates (UAE);Gastrointestinal Disorders;2024-07-07

3. Persistence and other treatment patterns among bio-experienced patients with Crohn’s disease initiated on ustekinumab or adalimumab;Journal of Managed Care & Specialty Pharmacy;2023-08

4. Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies;Journal of Crohn's and Colitis;2023-03-13

5. Effectiveness and safety of vedolizumab in biologically naïve patients: A real‐world multi‐centre study;United European Gastroenterology Journal;2020-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3